Patienter med moderate til svære eller recidiverende infusionsrelaterede reaktioner er vurderet for Myozyme - specifikke IgE- antistoffer; nogle patienter testedes positive, herunder en patient, der oplevede en anafylaktisk reaktion.
5 with moderate to severe or recurrent IARs have been evaluated for Myozyme specific IgE antibodies; some patients tested positive including one patient who experienced an anaphylactic reaction.